Photo taken from Amer Zeidan/X
Jun 18, 2024, 02:37
Amer Zeidan: A wonderful talk by Dr. Emma M. Groarke on targeting immune dysregulation in Myelodysplastic syndromes
Amer Zeidan shared a post on X:
“A wonderful talk by Dr. Emma M. Groarke on targeting immune dysregulation in Myelodysplastic syndromes (MDSs) & AA through cell therapy, ATG, immune checkpoint inhibitor and Jak inhibitors at EHA2024.”
Source: Amer Zeidan/X
Amer Zeidan is an Associate Professor of Medicine (Hematology) at Yale University. He is also the medical director of Hematology Early Therapeutics Research, the leader of the Myeloid Malignancies DART (Disease Aligned Research Team), and the director of Continuing Medical Education (CME) at the Hematology division and chairs the Protocol Review Committee (PRC) at Yale Cancer Center. Dr. Zeidan is a well-known leukemia researcher with a special focus on targeted therapies and immunotherapy for myeloid malignancies, and a social media influencer in the field of blood cancer.
Aug 10, 2024, 14:21